Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of dexmedetomidine as an adjuvant to sciatic nerve block in elderly patients
ChiCTR-IPR-15006078Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Apr 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine, lidocaine and ropivacaine in great saphenous vein varicosis (GSVV) (4 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: Sensory onset time of sural nerve, Sensory duration time of sural nerve and 34 more. Planned start Apr 2015; status: not yet recruiting.
02
Drugs
dexmedetomidinelidocaineropivacaine
03
Conditions
great saphenous vein varicosis (GSVV)
Beyond the preview
Go deeper on ChiCTR-IPR-15006078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006078.